drugset / Trial / NCT02999893
A Study of APR-246 in Oesophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether APR-246, 5-FU and cisplatin are safe and effective in the treatment of platinum resistant oesophageal cancer.
Timeline
- Start
- 2017-04-11
- Primary completion
- 2020-10-16
- Completion
- 2021-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | eprenetapopt | Small molecule | 50 mg/kg | Intravenous |
| Subject | eprenetapopt | Small molecule | 75 mg/kg | Intravenous |
| Subject | eprenetapopt | Small molecule | 100 mg/kg | Intravenous |